Epping, United Kingdom
Evaluation of a Conversational Information Collection Tool to Access Talk Therapy
Phase
N/ASpan
131 weeksSponsor
Limbic LimitedEpping
Recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Phase
3Span
314 weeksSponsor
Eli Lilly and CompanyEpping, Essex
Recruiting
1-2 of 2